Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent with type 2 diabetes and associated with significant morbidity and mortality.  

Thyroid hormone increases beta-oxidation of fatty acids and decreases intrahepatic lipid content.

Treatment with thyroid hormone reduces intrahepatic lipid content in subjects with Type 2 Diabetes Mellitus and NAFLD.

JCEM. 103(7). July 2018. 2698–2706